Security key
M40527109
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX)
CUSIP: M40527109
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Ordinary shares, par value NIS 0.0000769 per share
- Shares outstanding
- 45,504,462
- Total 13F shares
- 9,194,576
- Share change
- -1,016,426
- Total reported value
- $17,653,167
- Price per share
- $1.92
- Number of holders
- 21
- Value change
- -$1,951,360
- Number of buys
- 8
- Number of sells
- 8
Report period
Q3 2025
Institutions
21
Top holders
10
ENTX full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Entera Bio Ltd. SEC filings
Entera Bio Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M40527109
Recent filing periods:
Top shareholders of ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OPKO HEALTH, INC. |
13D/G
|
— |
8.1%
|
3,685,226
|
$8,660,281 | $0 | 16 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company |
2.6%
from 13D/G
|
2,697,236
|
$5,124,748 | — | 30 Jun 2025 | |
| Knoll Capital Management, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
13%
|
5,881,879
|
$11,175,570 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.3%
|
604,522
|
$1,148,591 | — | 30 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.78%
|
355,822
|
$676,062 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
200,745
|
$381,416 | — | 30 Jun 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.31%
|
140,843
|
$268,000 | — | 30 Jun 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.15%
|
67,544
|
$128,334 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
64,300
|
$122,170 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
48,877
|
$92,866 | — | 30 Jun 2025 | |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC |
13F
|
Company |
0.1%
|
47,328
|
$89,923 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
23,430
|
$44,517 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
21,136
|
$40,158 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
15,631
|
$29,699 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
11,656
|
$22,146 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
10,187
|
$19,355 | — | 30 Jun 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
10,000
|
$19,000 | — | 30 Jun 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.02%
|
9,000
|
$17,100 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
815
|
$1,549 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
51
|
$97 | — | 30 Jun 2025 | |
| Phillip Schwartz |
3/4/5
|
President of R&D, Director |
—
class O/S missing
|
607,410
|
$601,336 | — | 20 Jan 2022 | |
| Ramesh Ratan |
3/4/5
|
U.S.based CFO |
—
class O/S missing
|
10,000
|
$9,900 | — | 19 Jan 2022 | |
| Spiros Jamas |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
10,000
|
$9,900 | — | 18 Jan 2022 | |
| Roger Garceau |
3/4/5
|
Director |
—
class O/S missing
|
108,333
|
— | — | 01 Jan 2024 | |
| Ron Mayron |
3/4/5
|
Director |
—
class O/S missing
|
108,333
|
— | — | 01 Jan 2024 | |
| Arthur C. Santora II |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
35,000
|
— | — | 24 Apr 2023 |
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q3 2025
As of 30 Sep 2025,
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,194,576 shares.
The largest 10 holders included
Knoll Capital Management, LLC, Point72 Asset Management, L.P., MARSHALL WACE, LLP, Schonfeld Strategic Advisors LLC, Parkman Healthcare Partners LLC, NORTHERN TRUST CORP, BESSEMER GROUP INC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and SIGNATURE ESTATE & INVESTMENT ADVISORS LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
19
Q3 2025 holders
21
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.